|
15
|
100
|
5c0fB |
Hla-a02 carrying rqwgpdpaav |
|
77
|
276
|
5c0cA |
1e6 tcr in complex with hla-a02 carrying rqfgpdwiva |
|
34
|
200
|
5c0cD |
1e6 tcr in complex with hla-a02 carrying rqfgpdwiva |
|
14
|
100
|
5c0eB |
Hla-a02 carrying ylggpdfpti |
|
15
|
100
|
5c0gB |
Hla-a02 carrying ylggpdfpti |
|
15
|
100
|
5c0dB |
Hla-a02 carrying aqwgpdpaaa |
|
34
|
201
|
4eupG |
The complex between tcr jkf6 and human class i mhc hla-a2 presenting the mart-1(27-35)(a27l) peptide |
|
13
|
100
|
4eupB |
The complex between tcr jkf6 and human class i mhc hla-a2 presenting the mart-1(27-35)(a27l) peptide |
|
56
|
241
|
4eupH |
The complex between tcr jkf6 and human class i mhc hla-a2 presenting the mart-1(27-35)(a27l) peptide |
|
76
|
274
|
4eupA |
The complex between tcr jkf6 and human class i mhc hla-a2 presenting the mart-1(27-35)(a27l) peptide |
|
21
|
99
|
4e5xG |
Crystal structure of a complex between the human adenovirus type 2 e3-19k protein and mhc class i molecule hla-a2/tax |
|
78
|
275
|
4e5xA |
Crystal structure of a complex between the human adenovirus type 2 e3-19k protein and mhc class i molecule hla-a2/tax |
|
14
|
100
|
4e5xB |
Crystal structure of a complex between the human adenovirus type 2 e3-19k protein and mhc class i molecule hla-a2/tax |
|
14
|
100
|
3v5kB |
Hla2.1 kvaelvwfl |
|
74
|
275
|
3v5dA |
Hla-a2.1 kvaelvhfl |
|
14
|
100
|
3v5dB |
Hla-a2.1 kvaelvhfl |
|
71
|
275
|
3v5hA |
Hla-a2.1 kvaeivhfl |
|
15
|
100
|
3v5hB |
Hla-a2.1 kvaeivhfl |
|
71
|
275
|
3v5kA |
Hla2.1 kvaelvwfl |
|
14
|
100
|
3utsB |
1e6-a*0201-alwgpdpaaa complex, monoclinic |
|
79
|
276
|
3utqA |
Human hla-a*0201-alwgpdpaaa |
|
28
|
199
|
3uttD |
1e6-a*0201-alwgpdpaaa complex, triclinic |
|
66
|
275
|
3uttA |
1e6-a*0201-alwgpdpaaa complex, triclinic |
|
48
|
246
|
3utsE |
1e6-a*0201-alwgpdpaaa complex, monoclinic |
|
72
|
276
|
3utsA |
1e6-a*0201-alwgpdpaaa complex, monoclinic |
|
49
|
244
|
3uttE |
1e6-a*0201-alwgpdpaaa complex, triclinic |
|
40
|
200
|
3utsD |
1e6-a*0201-alwgpdpaaa complex, monoclinic |
|
14
|
100
|
3utqB |
Human hla-a*0201-alwgpdpaaa |
|
15
|
100
|
3uttB |
1e6-a*0201-alwgpdpaaa complex, triclinic |
|
15
|
99
|
3rewB |
Crystal structure of an lmp2a-derived peptide bound to human class i mhc hla-a2 |
|
79
|
275
|
3rewA |
Crystal structure of an lmp2a-derived peptide bound to human class i mhc hla-a2 |
|
81
|
275
|
5wshA |
Structure of hla-a2 p130 |
|
14
|
100
|
5wshB |
Structure of hla-a2 p130 |
|
0
|
9
|
5swqC |
Crystal structure of hla-a*0201 in complex with na231, an influenza epitope |
|
82
|
275
|
5swqA |
Crystal structure of hla-a*0201 in complex with na231, an influenza epitope |
|
67
|
275
|
5nhtH |
Human 199.54-16 tcr in complex with melan-a/mart-1 (26-35) peptide and hla-a2 |
|
37
|
201
|
5nmfI |
868 tcr in complex with hla a02 presenting slyntiatl |
|
16
|
99
|
5nmhB |
Hla a02 presenting slyntiatl |
|
49
|
242
|
5nmeE |
868 tcr in complex with hla a02 presenting slyntvatl |
|
13
|
100
|
5nmeB |
868 tcr in complex with hla a02 presenting slyntvatl |
|
1
|
9
|
5nmeC |
868 tcr in complex with hla a02 presenting slyntvatl |
|
13
|
100
|
5nmgB |
868 tcr in complex with hla a02 presenting slyfntiavl |
|
37
|
200
|
5nmgD |
868 tcr in complex with hla a02 presenting slyfntiavl |
|
55
|
239
|
5nmfE |
868 tcr in complex with hla a02 presenting slyntiatl |
|
74
|
276
|
5nmgA |
868 tcr in complex with hla a02 presenting slyfntiavl |
|
11
|
99
|
5nmfB |
868 tcr in complex with hla a02 presenting slyntiatl |
|
17
|
100
|
5nhtL |
Human 199.54-16 tcr in complex with melan-a/mart-1 (26-35) peptide and hla-a2 |
|
41
|
242
|
5nqkB |
Human 199.16 tcr in complex with melan-a/mart-1 (26-35) peptide and hla-a2 |
|
62
|
275
|
5nqkH |
Human 199.16 tcr in complex with melan-a/mart-1 (26-35) peptide and hla-a2 |
|
14
|
100
|
5nqkL |
Human 199.16 tcr in complex with melan-a/mart-1 (26-35) peptide and hla-a2 |
